Corteva (NYSE:CTVA) Issues FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 3.450-3.700 for the period, compared to the consensus EPS estimate of 3.650. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.1 billion.

Corteva Stock Down 2.4%

Shares of NYSE CTVA traded down $1.93 during mid-day trading on Thursday, hitting $79.84. The company had a trading volume of 1,926,717 shares, compared to its average volume of 3,966,357. The company has a market capitalization of $53.60 billion, a PE ratio of 46.92, a price-to-earnings-growth ratio of 2.88 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva has a 1-year low of $60.53 and a 1-year high of $85.63. The business’s 50-day simple moving average is $80.66 and its 200 day simple moving average is $72.48.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.88% and a net margin of 6.50%.The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period last year, the business posted $1.13 earnings per share. Corteva’s revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts predict that Corteva will post 3.62 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CTVA. Berenberg Bank upped their target price on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. UBS Group lifted their price target on shares of Corteva from $80.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, April 9th. Oppenheimer boosted their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Mizuho increased their price objective on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Finally, BNP Paribas Exane raised their price objective on shares of Corteva from $74.00 to $77.00 in a report on Wednesday. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $86.62.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.15% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of CTVA. Harris Associates L P grew its position in shares of Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the last quarter. Amundi boosted its stake in Corteva by 125.3% in the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after acquiring an additional 1,899,248 shares in the last quarter. Invesco Ltd. boosted its stake in Corteva by 16.7% in the fourth quarter. Invesco Ltd. now owns 11,404,960 shares of the company’s stock valued at $764,474,000 after acquiring an additional 1,630,712 shares in the last quarter. State Street Corp grew its holdings in shares of Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after purchasing an additional 1,290,071 shares during the last quarter. Finally, Man Group plc increased its position in shares of Corteva by 16,474.3% during the third quarter. Man Group plc now owns 1,294,125 shares of the company’s stock worth $87,522,000 after purchasing an additional 1,286,317 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.